- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01276028
Acupuncture in Menopause (AIM)
Acupuncture for Vasomotor Symptoms
Study Overview
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
North Carolina
-
Chapel Hill, North Carolina, United States
- Chapel Hill Doctors
-
Winston-Salem, North Carolina, United States, 27157
- Wake Forest University Baptist Medical Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Women experiencing on average 4 Hot Flashes a day
- Women aged 45-60
- Peri or Post menopausal Women (No periods for at least 3 months)
Exclusion Criteria:
- Women who have initiated CAM or non-CAM treatments for hot flashes in the last 4 weeks
- Women who have changed their dose of a CAM or non-CAM treatments for hot flashes in the last 4 weeks
- Women who have initiated antidepressants in the last 3 months
- Women who have changed their dose of an antidepressant in the last 3 months
- Women who have had acupuncture in the last 4 weeks
- Women who have received acupuncture from one of the study acupuncturists in the last 6 months will be excluded from the study
- Women who describe their health as fair or poor are excluded from the study
- Women who have a diagnosis of Hemophilia
- Relatives and Co-Workers of the treating acupuncturists
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: Acupuncture
This group will start acupuncture treatments within 3 weeks of consent and continue to receive up to 20 treatments over a six month period.
The number of treatments will be jointly determined by the participant and the acupuncturist.
|
For the Acupuncture group: Women will be eligible to receive from 1 to 20 treatments over a six month period. These women will receive an initial evaluation by a acupuncturist and will be given a Traditional Chinese Medicine (TCM) diagnosis as well as a recommended treatment schedule which they can then negotiate. Women in the waitlist group will not receive any acupuncture for 6 months. At the end of the 6 month period the participants will be allowed to begin the acupuncture treatments. |
|
OTHER: Waitlist
This group of participants will be asked to wait 6 months and will then be allowed to receive acupuncture.
|
For the Acupuncture group: Women will be eligible to receive from 1 to 20 treatments over a six month period. These women will receive an initial evaluation by a acupuncturist and will be given a Traditional Chinese Medicine (TCM) diagnosis as well as a recommended treatment schedule which they can then negotiate. Women in the waitlist group will not receive any acupuncture for 6 months. At the end of the 6 month period the participants will be allowed to begin the acupuncture treatments. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Subjective Hot Flashes
Time Frame: Up to 14 months
|
Hot Flashes will be monitored via daily diary.
This diary will be filled out daily for the first six months (post randomization) of the study and then 1 week per month for the remaining 6 months of the study.
|
Up to 14 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Objective Hot Flashes
Time Frame: 3 days
|
Objective hot flashes measured by skin conductance
|
3 days
|
|
Other Symptoms
Time Frame: Up to 14 months
|
Up to 14 months
|
|
|
Quality of Life
Time Frame: Up to 58 weeks
|
Measures your quality of life over the last week
|
Up to 58 weeks
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Nancy Avis, PhD, Wake Forest University Health Sciences
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- IRB00014892
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.